Page 1 - ABUS-Casestudy
P. 1
Best practices for
implementing ABUS
Breast care pathways – ABUS decision tree
This paper reviews best practices for integrating ABUS into patient care
across a variety of practice types in five European countries, including
Greece, Germany, Turkey, Italy and Spain. This includes private breast
centers, public hospitals, academic hospitals, and an obstetrics and
gynecology practice that offers breast health and oncology care
to patients.
Each case study outlines the breast care pathway – or ABUS decision tree –
in relation to the country’s breast cancer screening approach, guidelines,
overall acceptance of screening, and resources. In each case, ABUS has
been adopted as a key tool to improve early cancer detection, particularly
among women with dense breasts. Many sites are already informing
Sites at a glance patients about their breast composition and the benefits of supplemental
Dr. Athina Vourtsis, MD, PhD screening and using risk assessment models to personalize screening.
Athena Medical This includes offering a supplemental 3D ABUS exam directly after a
Athens, Greece digital mammogram or 3D tomosynthesis exam.
Dr. Alexander Henze, MD
Frauenärzte Gesundheitszentrum Breast density reduces
Aschaffenburg, Germany mammography sensitivity
Prof. Erkin Aribal, MD Breast cancer remains the most common cancer
Acibadem Altunizade Hospital amongst women across Europe, with an estimated
1
Istanbul, Turkey 576,300 new cases in 2020. In the “Position Paper on
Screening for Breast Cancer” published in European
Prof. Marco Moschetta, MD, PhD Radiology, EUSOBI (European Society of Breast
University Hospital Bari Imaging) attributes a 40% reduction in breast cancer
Bari, Italy mortality based on population-based screening. 2
Dr. Jose Carmelo Albillos Merino, MD Mammography is the gold standard for screening;
Hospital Universitario 12 de Octubre however, it does not work equally well for all women,
Madrid, Spain particularly those who have dense breast tissue. In
fact, studies show that mammography misses one-
Dr. Maria Teresa Fernández- third of cancers in patients with dense breasts. 3
Taranilla, MD, PhD
Hospital Universitario 12 de Octubre The information described here is based on each of the practitioner's own opinions
and on results that were achieved in his/her unique setting. Since there is no “typical”
Madrid, Spain hospital and many variables exist, i.e. hospital size, case mix, etc., results may vary.
